InhalPlus raised €500k in a Pre-Seed round in Oct 2026. The company is based in Hanover, Germany. Investors in the round: NBank Capital. Data as of 27 Oct 2026.
Reported in EUR — no conversion. €500k
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
